CytomX Therapeutics CTMX
NASDAQ CTMX
$2.56 -0.07 (-2.66%)
At close: Oct 2, 2026 · 4:00 PM EDT

CytomX Therapeutics (CTMX) Price to Earnings (2024 - 2025)

Updated

CytomX Therapeutics' Price to Earnings came in at 19.29 for Q3 2025, up 188.9% from 6.68 a year earlier and up 215.9% from the prior quarter.

Analysis

CytomX Therapeutics (CTMX) Price to Earnings (2024 - 2025) Analysis & Trends

For FY2024, CytomX Therapeutics' Price to Earnings was 2.59.

  • Business Quant data shows CTMX's Price to Earnings at 6.11 (Q2 2025), 1.24 (Q1 2025) and 2.59 (Q4 2024) in the three quarters before Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 CytomX Therapeutics 573.08 Mn -384.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 19.29
Jun 30, 2025 6.11
Mar 31, 2025 1.24
Dec 31, 2024 2.59
Sep 30, 2024 6.68
Jun 30, 2024 8.60
Mar 31, 2024 10.82
API Access

CytomX Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=CTMX&period=max&api_key=YOUR_API_KEY